Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
Open | $8.06 |
Close | $8.13 |
Volume / Avg. | 2.58M / 4.93M |
Day Range | 7.92 - 8.44 |
52 Wk Range | 1.42 - 8.29 |
Market Cap | $436.96M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 76 |
Short Interest | 14.78% |
Days to Cover | 2.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Other companies in Emergent BioSolutions’s space includes: Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Altimmune (NASDAQ:ALT), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
There is no analysis for Emergent BioSolutions.
Emergent BioSolutions has a consensus price target of $26.00.
The stock price for Emergent BioSolutions (NYSE: EBS) is $8.3386 last updated Today at July 8, 2024 at 5:12 PM EDT.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.